Stop the dry eye vicious cycle of inflammation for your dry eye patients! OptiLight, the first FDA-approved light therapy for dry eye disease has the potential to: 👏 Decrease the level of pro-inflammatory mediators to inhibit inflammation 👏 Significantly boost tear breakup time and decrease osmolarity 👏 Destroy the abnormal blood vessels that perpetuate inflammation 👏 Improve meibomian gland morphology and functionality 👏 Decrease population of Demodex mites which stimulate infection Learn